146 / 185
146
Diretrizes 2013
management. New York: Oxford University Press;
1993.
31. Henningfield JE, Keenan RM. Nicotine delivery
kinetics and abuse liability. J Consult Clin Psychol.
1993;61(5):743-50.
32. Benowitz NL. Pharmacology of nicotine:
addiction and therapeutics. Annu Rev Pharmacol
Toxicol. 1996;36:597-613.
33. Perkins KA, Grobe JE, Epstein LH, Caggiula A,
Stiller RL, Jacob RG. Chronic and acute tolerance to
subjective effects of nicotine. Pharmacol Biochem
Behav. 1993;45(2):375-81.
34. Porchet HC, Benowitz NL, Sheiner LB, Copeland
JR. Apparent tolerance to the acute effect of nicotine
results in part from distribution kinetics. J Clin
Invest. 1987;80(5):1466-71.
35. Benwell ME, Balfour DJ, Birrell CE.
Desensitization of nicotine-induced mesolimbic
dopamine responses during constant infusion with
nicotine. Br J Pharmacol. 1995;114(2):454-60.
36. Balfour DJ. The neurobiology of tobacco
dependence: a preclinical perspective on the role of
the dopamine projections to the nucleus accumbens
[corrected]. Nicotine Tob Res. 2004;6(6):899-912.
37. Snyder FR, Davis FC, Henningfield JE. The
tobacco withdrawal syndrome: performance
decrements assessed on a computerized test battery.
Drug Alcohol Depend. 1989;23(3):259-66.